IMT-01 THERAPEUTIC EFFECT AGAINST LOWER GRADE GLIOMA INDUCED BY DENDRITIC CELL BASED IMMUNOTHERAPY

BACKGROUND: This trial was designed to evaluate the safety and clinical responses to an immunotherapy with fusions of dendritic and glioma cells in patients with lower grade glioma (LGG; WHO grade II-III glioma). METHOD: Autologous cultured glioma cells obtained from surgical specimens were fused wi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neurooncol Adv
Glavni autori: Akasaki, Yasuharu, Takei, Jun, Kamata, Yuko, Yamamoto, Yohei, Mori, Ryosuke, Tanaka, Toshihide, Yanagisawa, Takaaki, Murayama, Yuichi
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213172/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.076
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items